XTL Biopharmaceuticals Ltd (XTLB)
1.83
+0.06
(+3.39%)
USD |
NASDAQ |
Nov 21, 16:00
1.67
-0.16
(-8.74%)
After-Hours: 20:00
XTL Biopharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2013 | 61.94% |
| June 30, 2013 | 63.28% |
| March 31, 2013 | 70.43% |
| December 31, 2012 | |
| September 30, 2012 | 54.52% |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 |
| Date | Value |
|---|---|
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | 87.72% |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | 87.72% |
| March 31, 2006 | |
| December 31, 2005 | |
| September 30, 2005 | |
| June 30, 2005 | 7.59% |
| March 31, 2005 | |
| December 31, 2004 | |
| September 30, 2004 | |
| June 30, 2004 | 1.95% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Compugen Ltd | 78.98% |
| Pluri Inc | 61.35% |
| BioLine Rx Ltd | 83.37% |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -- |